Readline
Latest round
- Series C
Last raised
- Feb 2025
Total raised
- $128M
Investors
- 12
About Readline
Established in 2017 and based in Shenzhen, China, Readline operates as an immobilized enzyme catalyst technology application services provider that provides innovative products and business solutions in the health, consumption, and agriculture industries. The company has bases located in Gansu, Zhuhai, and the UK. The company has acquired the IFRC Halal Award. The company has developed a green bio-intelligence platform ReBioHub, which covers biocomputing and AI, green chemistry, genetic engineering, enzyme engineering, cell engineering, fermentation engineering, intelligent automation, and quality research. Its products are divided into six series, which include effective skin care, nutrition and health, animal health, biomedicine, green agriculture and biomaterials, including myostatin, hexadecanedioic acid and derivatives, and collagen tripeptide, etc. The company generates revenue by providing synthetic biotechnology application services. The company will use the funds for setting up production bases in Changde and Shaoguan and improving production.
Who invested in Readline
12 investors across 5 rounds
See all investors in Readline
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Readline
Who invested in Readline?
Readline has 12 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Readline raised?
Readline has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Readline last raise money?
Readline's most recent round on record is a Series C, in Feb 2025.
What does Readline do?
Established in 2017 and based in Shenzhen, China, Readline operates as an immobilized enzyme catalyst technology application services provider that provides innovative products and business solutions in the health, consumption, and agriculture industries.
Where is Readline headquartered?
Readline is headquartered in Shenzhen, China.
Which VCs invest in companies like Readline?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Readline's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Readline? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.